Keywords: Biotech, IM, Funding, Rutter, Tax,

Subject to certain limitations, investors can choose between providing debt and equity funding to a start-up company. In cases in which the venture turns out to be unsuccessful, debt financing can provide significant tax advantages to the investor in the form of ordinary bad debt deductions. The recent US Tax Court case of Rutter v. Commissioner demonstrates the importance of proper tax planning in order to sustain the characterization of an advance to a biotech start-up as indebtedness for federal income tax purposes. Mark Leeds of the New York office of Mayer Brown analyzes this new case and provides insights on tax planning for investing in start-ups in the attached Mayer Brown Legal Update.

Get the full report

Visit us at

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2017. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.